Skin examinations every six months should be conducted, and patients with a known BAP1 mutation should have MBAITs removed as well as other lesions that change with time, along with ophthalmologic screening every year to monitor for uveal melanomas [33,34]. The gene discussed is BAP1; the disease is uveal melanoma.